Skip to main content
HeartCited

Berberine Metabolic Syndrome (Cardiovascular Aspects)

B

Improves multiple metabolic parameters: glucose, lipids, BMI, waist circumference. AMPK activation addresses insulin resistance — the core driver of metabolic syndrome.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dberberine\u0026condition\u003Dmetabolic\u002Dsyndrome\u002Dcardiovascular'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

結論

Improves multiple metabolic parameters: glucose, lipids, BMI, waist circumference. AMPK activation addresses insulin resistance — the core driver of metabolic syndrome.

Key Statistics

20

研究数

2500

参加者数

Positive

B

グレード

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:
500-1,500 mg/day divided TID
lipidsupport:
500 mg TID with meals

上限量: Not formally established; GI side effects limit doses >1,500 mg/day

推奨摂取タイミング: With meals, divided TID for sustained plasma levels; short half-life

Safety & Side Effects

報告されている副作用

  • Diarrhea (most common, usually resolves in 2 weeks)
  • Constipation
  • Flatulence
  • Abdominal pain
  • May lower blood sugar (monitor in diabetics)

既知の相互作用

  • Metformin (additive blood sugar lowering; may increase metformin levels)
  • CYP2D6 and CYP3A4 substrates (berberine is a CYP inhibitor)
  • Cyclosporine (may increase blood levels)
  • Macrolide antibiotics (may prolong QT interval)
  • Statins (complementary mechanism; monitor for additive effects)

耐容上限摂取量: Not formally established; GI side effects limit doses >1,500 mg/day

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does Berberine help with Metabolic Syndrome (Cardiovascular Aspects)?
Based on 20 studies with 2,500 participants, there is moderate evidence from clinical studies that Berberine may support Metabolic Syndrome (Cardiovascular Aspects) management. Our evidence grade is B (Good Evidence).
How much Berberine should I take for Metabolic Syndrome (Cardiovascular Aspects)?
Studies have used various dosages. A commonly studied range is 500-1,500 mg/day divided TID. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Berberine?
Reported side effects may include Diarrhea (most common, usually resolves in 2 weeks), Constipation, Flatulence, Abdominal pain. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Berberine and Metabolic Syndrome (Cardiovascular Aspects)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 20 peer-reviewed studies with 2,500 total participants. The overall direction of effect is positive.

Related Evidence

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。